PerkinElmer, Inc. (United States)
(NYSE : PKI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DXCMDexCom, Inc. 0.86%381.588.2%$1043.27m
ABTAbbott Laboratories -1.52%93.480.8%$670.94m
BDXBecton, Dickinson & Co. 0.00%246.941.0%$635.30m
DHRDanaher Corp. -0.44%165.880.7%$593.38m
MDTMedtronic Plc -0.31%98.270.6%$549.98m
TMOThermo Fisher Scientific, Inc. 0.33%350.351.0%$509.20m
INOInovio Pharmaceuticals, Inc. 1.56%14.986.3%$446.83m
BSXBoston Scientific Corp. -1.19%37.541.1%$404.56m
ISRGIntuitive Surgical, Inc. -0.64%576.332.4%$367.84m
SYKStryker Corp. 1.20%198.081.3%$367.12m
WSTWest Pharmaceutical Services, Inc. -1.09%213.681.6%$302.79m
ALGNAlign Technology, Inc. 1.58%249.516.4%$301.48m
BAXBaxter International, Inc. 0.85%90.781.8%$265.16m
QDELQuidel Corp. 0.53%175.927.7%$218.20m
MASIMasimo Corp. -0.95%237.915.2%$197.57m

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.